ASPHO Clinical Video Series

Microlearning for On-the-Go PHO Specialists

Fit learning into your busy day with the just-in-time Clinical Video Series featuring microlearning video segments for today’s on-the-go specialist. Gain the education tools you need in convenient, easy-to-access 15-20 minute visual lessons accompanied by narration and tutorials from experts in their fields. The video series features four segments each on Hematology/Anticoagulants and Oncology/Immunotherapy, with each lesson diving into standards of care, difficult or unique cases, emerging technologies, new research, and innovative therapies. Up to 2 AMA PRA Category 1 Credits™ available.

"ASPHO's Clinical Video Series is one of the best learning experiences I have encountered. The topics selected are key clinical issues in our field. The information shared is practical and concise - and delivered in a friendly manner! I enjoyed high reward for the time I spent listening. I am grateful to each of the speakers.” – John Van Doorninck, MD

"I found the Hematology video series to be extremely helpful. I was impressed with how much useful information was packed into such a concise and easily accessible format. The topics are excellent and very pertinent, and the video series positively influenced my clinical practice." - Arun Gurunathan, MD

ASPHO Clinical Video Series from ASPHO on Vimeo.

Hematology Set:

Anticoagulants - Pediatric Venous Thromboembolism (VTE)

Treatment Duration for Pediatric VTE
- Learning Objectives:
  - Review current literature recommendations regarding when to treat for pediatric VTE.
  - Identify the appropriate treatment duration for pediatric VTE.
  - Apply evidence-based guidelines to determine treatment recommendations for patients with symptomatic CVL-related thrombosis, asymptomatic CVL-related thrombosis, and unprovoked thrombosis.

Direct Oral Anticoagulants (DOACs)
- Learning Objectives:
  - List and describe the most commonly used DOACs.
  - Review published data from pediatric DOAC clinical trials.
  - Indicate practice considerations when prescribing DOACs, including dosing, laboratory monitoring, and managing bleeding.

Preventing and Treating VTE in Pediatric Cancer Patients
- Learning Objectives:
  - Understand risk factors for VTE in the setting of pediatric cancer patients.
  - Identify prevention strategies for VTE in pediatric cancer patients.
  - Determine management strategies for VTE in pediatric cancer patients.

Prevention of Hospital-Acquired Pediatric VTE
- Learning Objectives:
  - Review the epidemiology of hospital acquired pediatric VTE.
  - Identify prevention strategies for hospital acquired pediatric VTE.
  - Understand pediatric VTE complications in post-surgical patients and patients with COVID-19, determining indications for thromboprophylaxis.

Speaker

Sarah OBrien

Sarah O’Brien, MD MSc
Nationwide Children's Hospital
Columbus, OH

Oncology Set:

Immunotherapies for Pediatric Cancer

Immunotherapy for Hodgkin Lymphoma
- Speaker: Peter Cole, MD
  - Learning Objectives:
    - Understand the history and background of immunotherapy.
    - Review the mechanisms of action and clinical trial data related to Antibody-Drug Conjugates and Checkpoint inhibitors for pediatric patients with relapsed or refractory Hodgkin lymphoma.
    - Identify the immunotherapeutic strategies of combining conventional chemotherapy with other immunotherapies.

Acute Leukemia: BiTE Antibodies in Childhood Cancer
- Speaker: Lia Gore, MD
  - Learning Objectives:
    - Understand the background and mechanisms of use for BiTEs in the context of immunotherapies for childhood cancers.
    - Review clinical trial information regarding current use of cancer antigens and BiTEs for childhood ALL.
    - Identify current considerations, implications, and best practices with using BiTEs to treat childhood cancer patients.

Acute Leukemia: Immunotoxins and Antibody Drug Conjugates (ADCs)
- Speaker: Lia Gore, MD
  - Learning Objectives:
    - Understand the background and mechanisms of use for Antibody-Drug Conjugates (ADCs) in the context of cancer therapy.
    - Review the current literature supporting the evolution and use of immunotherapies and ADCs for ALL and childhood hematologic malignancies.
    - Describe clinical trial developments and identify the challenges associated with using ADCs to treat childhood cancer patients.

CAR-T Cell Therapy
- Speaker: Shannon Maude, MD PhD
  - Learning Objectives:
    - Understand the design, structure, function, and mechanism of CAR T-Cell immunotherapy in the context of cancer therapy.
    - Review the current literature supporting the use of CAR- T Cell therapy for ALL in childhood cancer patients.
    - Describe clinical trial developments and identify the challenges and potential expanded use of CAR-T Cell therapy to treat childhood cancer patients.

Speakers

petercole

Peter Cole, MD
Rutgers Cancer Institute of New Jersey

liagore

Lia Gore, MD
University of Colorado School of Medicine
Children’s Hospital Colorado

shannonmaude

Shannon Maude, MD PhD
Children’s Hospital of Philadelphia
The University of Pennsylvania School of Medicine

Pricing:

The Clinical Video Series is available in a variety of convenient and customizable purchase options. Plus, members receive exclusive savings! Not a member? Learn more about joining ASPHO.

Learners can purchase the Hematology and Oncology Sets together as a discounted bundle and access even more learning.

Full Series (includes both the Hematology and Oncology Sets)

Member: $170
Trainee/Medical Student/Resident Member: $85
Non-member: $270

Purchase the Full Series

Not interested in the full series? The Hematology and Oncology Sets are available individually or for single episode purchases.

Single Set (Hematology Set or Oncology Set)

Member: $99
Trainee/Medical Student/Resident Member: $50
Non-member: $160

Purchase the Hematology Set

Purchase the Oncology Set

Single Episodes

Member: $30
Trainee/Medical Student/Resident Member: $15
Non-member: $50

Purchase single episodes using the links below:

Continuing Medical Education Credit

The American Society of Pediatric Hematology/Oncology (ASPHO) offers continuing medical education (CME) credit for sessions viewed and evaluated. A certificate will be issued upon receipt of the evaluation. ASPHO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

ASPHO designates this activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ASPHO requires all planners, faculty (presenters and moderators), reviewers, and any others involved in the development of CME content to disclose all financial relationships they have with ineligible companies in the last 24 months. Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. ASPHO also requires disclosure of the intent to discuss unlabeled or investigational use(s) of a commercial product or investigational use of a product not yet approved for this purpose. The ASPHO Accreditation Subcommittee reviews all financial relationships as submitted in the disclosure form by planners and presenters and mitigates such conflicts to ensure the content of the activity is aligned with the interests of the public.

To view the 2021 Clinical Video Series speaker, planner, and reviewer disclosures, click here.

Disclaimer

The material presented in this activity represents the opinion of the speakers and not necessarily the views of ASPHO.

Evaluation

To access the evaluation, log into your My Library with your ASPHO username and password. Click on the graduation cap next to “Clinical Video Series” for each episode.

0.25 CME hour is available for each episode (up to 1.0 CME hour for each series, and up to 2.0 CME hours total for both series).